CSL Limited Upgraded at Deutsche Bank (CSL)
A number of other firms have also recently commented on CSL. Analysts at Credit Suisse reiterated an “outperform” rating on shares of CSL Limited in a research note on Wednesday, August 13th. They now have a $74.55 price target on the stock. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of A$74.28 ($69.42).
Shares of CSL Limited (ASX:CSL) traded up 1.28% during mid-day trading on Tuesday, hitting A$71.930. 1,520,472 shares of the company’s stock traded hands. CSL Limited has a one year low of A$63.770 and a one year high of A$72.820. The stock has a 50-day moving average of A$67.33 and a 200-day moving average of A$69.03. The company has a market cap of A$34.152 billion and a price-to-earnings ratio of 26.39.
CSL Limited is an Australia-based company. The Company is engaged in the research, development, manufacture, marketing and distribution of biopharmaceutical and allied products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.